CTTH - CTT Pharmaceutical Holdings, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1400
+0.0080 (+6.06%)
At close: 3:21PM EST
Stock chart is not supported by your current browser
Previous Close0.1320
Open0.1210
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1210 - 0.1740
52 Week Range0.1100 - 0.5800
Volume25,900
Avg. Volume34,526
Market Cap20.124M
Beta (5Y Monthly)1.16
PE Ratio (TTM)N/A
EPS (TTM)-0.0800
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    CTT Pharmaceuticals provides Corporate Update

    HAMILTON, ON, Dec 23, 2019 /CNW/ - CTT Pharmaceutical Holdings, Inc., (the "Company" or "CTT") (OTC:CTTH - News), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, today provides an update on the successful commercial introduction of its sublingual strips with Aurora Cannabis and intentions for product portfolio expansion. On October 6, 2019, Aurora Cannabis Inc. ("Aurora") commenced sales of its Dissolve Strips, developed in collaboration with CTT, to the Canadian medical market.

  • Aurora Cannabis Provides Corporate Update and Confirms Cannabis 2.0 Roll Out
    CNW Group

    Aurora Cannabis Provides Corporate Update and Confirms Cannabis 2.0 Roll Out

    EDMONTON, Dec. 23, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today provided an update on the readiness of its operations with the introduction of new product formats, recent industry recognitions and updates to existing operations. As a global leader in cannabis revenues, cannabis production, research, innovation and international market development, the Company intends to provide regular updates to its stakeholders in an effort to demonstrate continued transparency and disclosure.

  • CNW Group

    Aurora Cannabis Announces Change to Executive Team: Cam Battley Steps Away From his Role as Chief Corporate Officer

    EDMONTON , Dec. 21, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, announces a change to the Executive Team. Cam Battley has stepped down as Chief Corporate Officer effective December 20, 2019 . Mr. Battley joined Aurora in 2016, serving a number of senior roles critical to the success of the company in its early years before being named Chief Corporate Officer in 2018.

  • CNW Group

    Aurora Cannabis Achieves Highest Cannabis Corporate Boards Ranking in 2019 Globe & Mail Board Games Report

    EDMONTON, Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, is pleased to acknowledge the Company's ranking in the 2019 annual Report on Business ("ROB") review of Corporate Boards, known as Board Games. Published in its 18th year, the ROB Board Games considers dozens of governance criteria, extending beyond those required by formal regulations. Aurora achieved a score of 67 (out of a total score of 100), representing a significant increase over the prior year, a substantially higher ranking than others in its peer group of companies.

  • CNW Group

    Aurora Receives First Approval for Medicinal Cannabis Product in Ireland

    EDMONTON, Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that one of the Company's oil products has now been approved for use under Ireland's new Medical Cannabis Access Programme (MCAP). Aurora's High CBD Oil Drops received approval from the Irish authorities and have now been added to a regulatory schedule by the Irish Minister of Health enabling importation, prescribing and supply under the scheme and is to date, one of only two products to gain such authorization.

  • Aurora Cannabis Opens Experiential Flagship Store in North America's Largest Mall
    CNW Group

    Aurora Cannabis Opens Experiential Flagship Store in North America's Largest Mall

    EDMONTON , Nov. 27, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced the grand opening of its flagship retail store at 10:00 a.m. MT on November 27 th in the West Edmonton Mall, North America's largest mall. At approximately 11,000 square feet, Aurora has combined both a retail cannabis store and an immersive experiential space, encouraging visitors from around the world to explore unique products and participate in a rotating calendar of programming and events. Aurora's flagship store offers visitors a safe, age-gated retail experience in full compliance with all relevant federal and provincial regulations.

  • CNW Group

    CTT Pharma Strengthens Board and Management Team

    HAMILTON, ON, Nov. 27, 2019 /CNW/ - CTT Pharmaceutical Holdings, Inc., (the "Company" or "CTT") (OTC:CTTH - News), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, announced today several additions to its Board of Directors and management team. Effective immediately, Robert (Bob) Allen has been appointed CFO, Dana Buschmann has been appointed Director (Independent), and Marc Lakmaaker has been named strategic advisor to the Company.

  • CNW Group

    Aurora Cannabis Announces Pricing of Early Amended Conversion Privilege for Convertible Debentures

    NYSE | TSX: ACB   EDMONTON , Nov. 25, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, ...

  • CNW Group

    View from the C-Suite: Glen Ibbott, Chief Financial Officer, Aurora Cannabis Inc., tells his company's story. Filmed on October 16, 2019

    TORONTO , Nov. 20, 2019 /CNW/ -   https://youtu.be/LwWkYrANzec The View from the C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX ...

  • CNW Group

    Aurora Cannabis Strengthens Leadership Team Adding Chief Product Officer and Chief Integration Officer

    Appoints Dr. Shane Morris CPO and André Jérôme CIO TSX | NYSE: ACB   EDMONTON , Nov. 20, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian ...

  • CNW Group

    Aurora Cannabis Provides Preliminary Update on Convertible Debenture Temporary Early Amended Conversion Privilege

    93.8% of Debenture Holders Have Elected to Voluntarily Convert EDMONTON , Nov. 19, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company ...

  • CNW Group

    Aurora Cannabis Announces Temporary Amended Early Conversion Privilege for its 2020 Convertible Debentures

    TORONTO , Nov. 14, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that it has provided notice to all holders (the "Debentureholders") of the Company's CAD$230 million 5% unsecured, convertible debentures due March 9, 2020 (the "Debentures") of an opportunity to voluntarily convert their Debentures at the Amended Early Conversion Ratio (as defined herein). All Debentureholders will be able to convert their Debentures at the Amended Early Conversion Ratio during the period commencing on November 18, 2019 and ending at 5:00 p.m. ( Toronto time) on November 20, 2019 (the "Early Conversion Period").

  • CNW Group

    Aurora Cannabis Announces First Quarter 2020 Results & Corporate Action Plan

    NYSE | TSX: ACB Reports Industry Leading Gross Profit of $53.7 Million and 58% Cannabis Gross Margin Delivers Best-in-Class Indoor Cash Cost to Produce of $0.85 per gram Announces Plan to Settle March ...